RenThyroid NDC 64950-172

NDC codes

FDA NDC Directory

Product NDC (as listed)64950-172Labeler and product segments. Claims need a package NDC.

Product NDC at billing width64950-0172Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
64950-172-01	64950017201	100 TABLET in 1 BOTTLE (64950-172-01)Marketed from Mar 1, 2025
64950-172-09	64950017209	90 TABLET in 1 BOTTLE (64950-172-09)Marketed from Mar 1, 2025
64950-172-14	64950017214	14 TABLET in 1 BOTTLE (64950-172-14)Marketed from Mar 1, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): RenThyroid
Generic name (nonproprietary): levothyroxine and liothyronine
Active ingredients: Levothyroxine — 38 ug/1Liothyronine — 9 ug/1
Dosage form: Tablet
Route: Oral
Labeler: Genus Lifesciences
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Mar 1, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Thyroxine (Chemical structure)Triiodothyronine (Chemical structure)
Identifiers: Product ID 64950-172_dd8b277c-6ec2-4e0b-9aec-c64089e18cfeSPL ID dd8b277c-6ec2-4e0b-9aec-c64089e18cfeSPL set ID 0f0c1875-7706-43ec-a9ef-ad82a49e46ecRxCUI 198278, 208545, 313387, 313391, 313393, 314267, 2706315, 2706317, 2706319, 2706321, 2706323, 2706325, 2706327, 2706329, 2706331, 2706333UNII Q51BO43MG4, 06LU7C9H1VUPC 0364950171013, 0364950170016, 0364950180015, 0364950175011, 0364950172010, 0364950173017, 0364950179019, 0364950174014
Pharmacologic class: l-Thyroxine; l-Triiodothyronine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N464950017201 followed by a unit qualifier and the quantity

Package 64950-0172-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 27, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE RenThyroid (Thyroid Tablets, USP) are indicated: As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. This category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism (See WARNINGS ). As …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)